Electrospun Hyaluronic Acid/Polyvinyl Alcohol Nanofibers Encapsulating Defactinib as Bioactive Dressings for Burn Wound Therapy
ACS Applied Bio Materials · 06.04.2026 · 9 (7) · 3349-3361
DOI: 10.1021/acsabm.5c02361 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 12.03.2026. Verfasst von Deepak Chouhan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience and Pain Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu Unive…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Burns, Nanofibers, Polyvinyl Alcohol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Indian Council of Medical Research, Ministry of Education, India.
Abstract (Originalsprache)
Chronic burn wounds remain a significant clinical challenge due to prolonged inflammation, delayed tissue regeneration, and limited effectiveness of current topical therapies. In this study, electrospun hyaluronic acid/poly(vinyl alcohol) (HA/PVA) nanofiber scaffolds loaded with Defactinib, a focal adhesion kinase inhibitor, were developed to promote burn wound healing through localized drug delivery. Optimized electrospinning conditions produced uniform, bead-free nanofibers with stable amorphous drug dispersion, as confirmed by SEM, TEM, XRD, and DSC analyses. The Defactinib-loaded nanofibers exhibited (DFT-NF) high drug entrapment efficiency, good hydrophilicity, and a biphasic release profile characterized by an initial burst followed by sustained release over 24 h. In a rat burn wound model, treatment with Defactinib-loaded nanofibers significantly accelerated wound closure compared with untreated and standard-treated groups. Non-invasive photoacoustic imaging enabled real-time monitoring of wound healing, revealing increased vascularity and improved tissue oxygen saturation in treated wounds by Day 21, indicative of enhanced vascular recovery. Histological evaluation further confirmed improved re-epithelialization, reduced inflammatory infiltration, and well-organized collagen deposition. Consistent with these findings, RT-PCR analysis showed marked suppression of key pro-inflammatory mediators (NF-κB, IL-1β, TNF-α, and IL-6) in the DFT-NF group, highlighting its potent anti-inflammatory activity. Overall, this study demonstrates that Defactinib-loaded HA/PVA nanofiber scaffolds, combined with imaging-based functional assessment, represent a promising and clinically relevant platform for advanced burn wound management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroscience and Pain Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, UP 221005, India.
- Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, UP 221005, India.
Förderung
- Indian Council of Medical Research
- Ministry of Education, India
Zitieren
APA
Chouhan, D., Jain, D., Singh, A. K., Jha, A., Londhe, R. D., Mishra, B., & Tiwari, V. (2026). Electrospun Hyaluronic Acid/Polyvinyl Alcohol Nanofibers Encapsulating Defactinib as Bioactive Dressings for Burn Wound Therapy. ACS Applied Bio Materials, 9(7), 3349-3361. https://doi.org/10.1021/acsabm.5c02361
Vancouver
Chouhan D, Jain D, Singh AK, Jha A, Londhe RD, Mishra B, et al. Electrospun Hyaluronic Acid/Polyvinyl Alcohol Nanofibers Encapsulating Defactinib as Bioactive Dressings for Burn Wound Therapy. ACS Applied Bio Materials. 2026;9(7):3349-3361. doi:10.1021/acsabm.5c02361
BibTeX
@article{Chouhan2026,
author = {Chouhan, Deepak and Jain, Darshita and Singh, Anurag Kumar and Jha, Abhishek and Londhe, Rohan Dattatray and Mishra, Brahmeshwar and Tiwari, Vinod},
title = {Electrospun Hyaluronic Acid/Polyvinyl Alcohol Nanofibers Encapsulating Defactinib as Bioactive Dressings for Burn Wound Therapy},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {7},
pages = {3349--3361},
doi = {10.1021/acsabm.5c02361}
}
EUVIMED